What is the dosage and usage of Chloramphenicol for adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chloramphenicol Dosage and Usage for Adults

Standard Adult Dosing

For most serious bacterial infections in adults, chloramphenicol should be administered at 50 mg/kg/day divided into four equal doses given every 6 hours intravenously, which typically translates to approximately 3-4 grams per day for an average adult. 1

  • The standard dose of 50 mg/kg/day in divided doses every 6 hours produces blood levels of 10-20 μg/mL, which is the therapeutic range effective against most susceptible organisms 1, 2
  • For severe infections requiring higher concentrations (such as bacteremia or meningitis), doses may be increased up to 100 mg/kg/day, but this should be reduced to 50 mg/kg/day as soon as clinically feasible 1

Administration Route and Technique

  • Intravenous administration is preferred, prepared as a 10% solution (100 mg/mL) by adding 10 mL of sterile water or 5% dextrose, and injected over at least one minute 1
  • Oral formulations have comparable bioavailability to IV preparations, making oral chloramphenicol highly effective when the patient can tolerate enteral administration 2, 3
  • Switch to oral therapy as soon as feasible once the patient's condition stabilizes 1

Specific Clinical Indications

Plague Treatment

  • For pneumonic or septicemic plague in adults, use 12.5-25 mg/kg every 6 hours IV (maximum 1 g/dose) 4
  • The lower end of this range (12.5 mg/kg every 6 hours) is sufficient for most plague cases, with higher doses reserved for severe infections 4
  • Treatment duration is 10-14 days 4

Meningitis

  • For pneumococcal meningitis in adults with cephalosporin allergy, use 25 mg/kg IV every 6 hours 5
  • Chloramphenicol is bactericidal against Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis, making it effective for bacterial meningitis 3
  • Treatment duration is 10-14 days depending on clinical response 5

Tularemia

  • For mild-to-moderate tularemia, chloramphenicol has been used at 2-3 g daily in 4 divided doses (approximately 500-750 mg every 6 hours) 4
  • Note that oral chloramphenicol is no longer distributed in the United States 4

Anaerobic Infections

  • For brain abscesses, intra-abdominal infections, and other severe anaerobic infections (excluding endocarditis), use standard dosing of 50 mg/kg/day divided every 6 hours 2, 6
  • Chloramphenicol has excellent tissue penetration, including into the central nervous system, making it particularly valuable for brain abscesses 2, 6

Dosage Adjustments for Special Populations

Hepatic or Renal Impairment

  • Reduce dosage in patients with impaired hepatic or renal function, as these patients have reduced ability to metabolize and excrete the drug 1
  • Serum concentration monitoring should be performed when available to maintain therapeutic levels of 10-20 μg/mL while avoiding toxicity 1, 2

Elderly Patients

  • Among elderly patients (≥65 years) with plague, chloramphenicol showed 100% survival in a small case series (n=2), suggesting efficacy in this population 4
  • Standard dosing applies, but monitor closely for adverse effects and consider dose reduction if hepatic or renal function is impaired 1

Critical Monitoring Parameters

  • Serum concentration monitoring is essential, targeting therapeutic levels of 10-20 μg/mL 4, 1
  • Monitor complete blood count with differential to detect reversible bone marrow suppression, which occurs more commonly than aplastic anemia 6
  • The maximum recommended dose is generally considered to be 8-9 grams per day for adults, though some sources cite up to 100 mg/kg/day for severe infections 6, 1

Safety Considerations and Toxicity

Bone Marrow Effects

  • Reversible bone marrow suppression is dose-related and can be minimized by using recommended doses and monitoring blood levels 3, 6
  • Aplastic anemia is extremely rare (estimated 1 in 20,000 to 1 in 40,000 patients) and appears to be idiosyncratic rather than dose-related 2, 3
  • In a recent survey, 37% of clinicians observed reversible bone marrow suppression at least once, while only one encountered aplastic anemia 6

Other Adverse Effects

  • Anemia occurs more frequently with chloramphenicol compared to other antibiotics (RR 2.80) 7
  • Gastrointestinal side effects are actually less frequent with chloramphenicol compared to alternatives (RR 0.67) 7
  • Gray baby syndrome is not a concern in adults, as this occurs only in neonates with immature hepatic metabolism 1, 2

When to Avoid Chloramphenicol

  • Do not use as first-line therapy for respiratory tract infections, meningitis (when alternatives are available), or enteric fever, as other antibiotics show superior efficacy 7
  • Chloramphenicol should be reserved as an alternative antibiotic for patients with polyvalent allergies, bacterial resistance to preferred agents, or treatment failure with other antibiotics 6
  • Avoid in pregnancy due to risk of hepatotoxicity 8

Current Role in Clinical Practice

  • Chloramphenicol is currently used in approximately 37% of hospitals, typically treating up to 10 patients per year 6
  • Most common indications include brain abscesses, purulent meningitis, intra-abdominal and pelvic abscesses, lung abscesses, and polymicrobial infections with anaerobes 6
  • When properly indicated and with appropriate monitoring, chloramphenicol remains a valuable and sometimes life-saving alternative antibiotic 6

References

Research

Chloramphenicol: properties and clinical use.

Pediatric infectious disease, 1982

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Streptococcus pneumoniae Meningitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Role of chloramphenicol in current clinical practice].

Klinicka mikrobiologie a infekcni lekarstvi, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.